The potential use of L-sulforaphane for the treatment of chronic inflammatory diseases: A review of the clinical evidence
Nadia Mazarakis, Kenneth Snibson, Paul V Licciardi, Tom C Karagiannis
CLINICAL NUTRITION | CHURCHILL LIVINGSTONE | Published : 2020
According to the World Health Organisation, 70% of all deaths globally can be attributed to chronic inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, respiratory conditions, cardiovascular diseases, diabetes and cancer. Chronic inflammation has a significant impact on the quality of life of affected individuals with an increased risk of developing other chronic inflammatory diseases. Given the limitations of current pharmaceuticals, there is an intense research interest in identifying novel dietary interventions that can regulate and alleviate inflammation. A diet rich in cruciferous vegetables has been extensively studied for its immediate and long-term health ..View full abstract
McCord Research (Iowa, USA), Australian Research Council Future Fellowship, NHMRC career development fellowship, Australian Government Research Training Program Scholarship.